Daniel Malandrin has departed from Valetec Capital, a Brazil-based investment management firm, where he managed DX Ventures on behalf of local construction materials producer Dexco.
Malandrin has joined professional services firm KPMG’s Brazilian subsidiary, KPMG Brazil, as partner of venture capital and corporate ventures. He has simultaneously taken up a partner role at the corporate’s open innovation arm, KPMG & Distrito Leap.
Valetec Capital hired Malandrin in May 2021 as a venture partner and DX Ventures head of investments for him to oversee the latter’s strategic investments.
Prior to that, Malandrin had spent more than a year at big data technology provider Semantix Brasil as managing director and head of corporate development and new ventures from early 2020, after more than six years as head of financial services firm Bradesco’s InovaBra Ventures unit. GCV named Malandrin a Rising Star in 2017 and an Emerging Leader three years later.
Founded in 2010, Valetec Capital is a CVC-as-a-service firm that runs corporate venturing funds. It manages corporate venturing units including Neuron Ventures and Algar Ventures, part of pharmaceutical firm Eurofarma and conglomerate Grupo Algar respectively.
DX Ventures was formed in 2021 and invests in startups that have a strategic fit with Dexco. Its portfolio companies include social commerce marketplace Facily and Brasil ao Cubo, a digital constructions technology provider.
Regarding his departure, Malandrin said on LinkedIn: “During my time at Valetec, I had the opportunity to develop DX Ventures, a CVC initiative of Dexco (ex-Duratex).
”It was a privilege to work with the Dexco team and meet amazing companies and executives, especially from Urbem, NoahTech Brasil and Brasil ao Cubo. I wish to thank Peter Seiffert and Luis Gustavo Amorim for the opportunity to work together, fostering the CVC market in Brazil.”
Image courtesy of KPMG & Distrito Leap. Photo of Daniel Malandrin courtesy of LinkedIn.